Decibel Therapeutics, Inc. discovers and develops medicines to protect, repair, and restore hearing. The firm focuses on hearing disorders, including noise-induced hearing loss, residual hearing preservation or improved sound fidelity with cochlear implants, presbycusis or age-related hearing loss, tinnitus, a persistent ringing in the ears, and genetic hearing loss. It also offers drugs for pediatric cancer and cystic fibrosis patients who experience ototoxicity or hearing loss. The company was founded in October 2015 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Decibel Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Decibel Therapeutics Inc market cap is $123.37M.
What is the 52-week high for Decibel Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Decibel Therapeutics Inc 52 week high is $5.40 as of September 06, 2025.
What is the 52-week low for Decibel Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Decibel Therapeutics Inc 52 week low is $1.61 as of September 06, 2025.
What is Decibel Therapeutics Inc stock price today?
Decibel Therapeutics Inc stock price today is $4.93.
What was Decibel Therapeutics Inc stock price yesterday?
Decibel Therapeutics Inc stock price yesterday was $4.95.
What is the PE ratio of Decibel Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Decibel Therapeutics Inc’s P/E ratio is -1.94.
What is the Price-to-Book ratio of Decibel Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Decibel Therapeutics Inc P/B ratio is 2.3142.
What is Decibel Therapeutics Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Decibel Therapeutics Inc's EBITDA is -0.49.
What is the 50-day moving average of Decibel Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Decibel Therapeutics Inc 50-day moving average is $4.50.